Comparison Between Two Ss-OCT Biometry
Launched by VIENNA INSTITUTE FOR RESEARCH IN OCULAR SURGERY · Apr 2, 2020
Trial Information
Current as of July 09, 2025
Completed
Keywords
ClinConnect Summary
This a retrospective study including data acquired from patients that attended pre-surgical examination as it is the standard in the investigator's hospital.
The IOL Master 700 (Carl Zeiss Meditec AG, Jena) and the Heidelberg Anterion (Heidelberg Engineering, Germany) are biometry devices that use swept-source optical coherence tomography technology in combination with a multidot-keratometer, that obtain two-dimensional images of ocular structures.
The difference between the two devices resides in the wavelength of the infrared laser: 1200-1400nm for the Anterion and 1050nm for the IOL Ma...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age-related cataract
- Exclusion Criteria:
- • nystagmus
- • physical inabilities that could interfere with fixation
- • dens cataract
- • macular or corneal pathologies that could compromise fixation during the measurements.
About Vienna Institute For Research In Ocular Surgery
The Vienna Institute for Research in Ocular Surgery is a leading clinical research organization dedicated to advancing the field of ophthalmic surgery through innovative research and development. Committed to enhancing patient outcomes and safety, the institute conducts rigorous clinical trials that explore new surgical techniques, devices, and treatment protocols for various ocular conditions. With a multidisciplinary team of experts in ophthalmology, surgery, and medical research, the institute aims to bridge the gap between scientific discovery and clinical application, fostering collaboration with healthcare professionals and industry partners to drive advancements in ocular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Oliver Findl, Prof., MD
Principal Investigator
VIROS, Hanusch Hospital Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials